Clearing & Transaction Fees was Cme’s largest product and service line in fiscal 2025, bringing in $5.28B of $6.52B (81%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Clearing & Transaction Fees | $4.14B | $4.59B | $4.99B | $5.28B | ||||||
| Marketdata | $610.90M | $663.70M | $710.20M | $803.10M | ||||||
| Otherrevenue | $265.80M | $326.70M | $431.70M | $436.40M | ||||||
| Total | $5.02B | $5.58B | $6.13B | $6.52B |
Cme brought in $6.52B from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 6.4% from $6.13B in fiscal 2024. Clearing & Transaction Fees was the largest at $5.28B (81.0%), ahead of Marketdata at $803.10M (12.3%) and Otherrevenue at $436.40M (6.7%).
Compared with fiscal 2024, Marketdata grew fastest, up 13.1% to $803.10M. Every line above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these lines grew from $5.02B to $6.52B, a compound annual growth rate of 9.1%. Clearing & Transaction Fees' share of the total fell from 82.5% to 81.0%.
Cme (CME) reports its revenue by product and service. In fiscal 2025, Clearing & Transaction Fees was its largest product and service line, bringing in $5.28B (81.0% of the total), followed by Marketdata at $803.10M (12.3%).
Clearing & Transaction Fees was Cme's largest product and service line in fiscal 2025, bringing in $5.28B, or 81.0% of the $6.52B total across its three product and service lines.
Among Cme's product and service lines that make up at least 2% of revenue, Marketdata grew fastest in fiscal 2025, up 13.1% from $710.20M to $803.10M.
Every figure comes from Cme's annual financial filings, as reported. Each line keeps the name Cme gives it, and years follow its fiscal calendar.
Cme's revenue by product and service goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.